Potential of CBD in Reducing Inflammation Associated with Alzheimer’s Disease
Introduction to Cannabidiol
Cannabidiol (CBD) is one of the more than 100 compounds derived from the cannabis plant. Unlike tetrahydrocannabinol (THC), which is known for its psychoactive effects, CBD is non-psychoactive. Research has indicated that CBD may possess anti-inflammatory and antioxidant properties, making it a subject of interest for various health applications.
Previous Research on CBD
Several studies have explored the therapeutic potential of CBD for a wide range of health issues. These include its effectiveness in managing epileptic seizures, anxiety, migraines, chronic pain, post-traumatic stress disorder (PTSD), glaucoma, and alleviating symptoms related to cancer.
New Findings on CBD and Alzheimer’s Disease
A recent study published in the journal eNeuro presents preliminary evidence that CBD may also be beneficial in addressing neuroinflammation related to Alzheimer’s disease. This research utilized a mouse model to investigate the potential of CBD in this context, suggesting a new avenue for therapeutic exploration in treating neurodegenerative disorders.